e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Exercise intolerance: mechanism, intervention and assessment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of exercise in skeletal muscle mitochondrial DNA content in COPD
L. Puente-Maestu, F. Villar, A. Ferreira, J. de Miguel, S. Caramllo, A. Tejedor (Madrid, Spain)
Source:
Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Session:
Exercise intolerance: mechanism, intervention and assessment
Session type:
E-Communication Session
Number:
411
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Puente-Maestu, F. Villar, A. Ferreira, J. de Miguel, S. Caramllo, A. Tejedor (Madrid, Spain). Effects of exercise in skeletal muscle mitochondrial DNA content in COPD. Eur Respir J 2008; 32: Suppl. 52, 411
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Oxidative DNA damage and mitochondrial DNA depletion in COPD locomotor muscle
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
Uncoupling protein 3 content is decreased in skeletal muscle of patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 88s
Year: 2002
Reduced mitochondrial density in the quadriceps muscle of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 621s
Year: 2006
Effects of exercise on ubiquitination and proteasome activity in skeletal muscle in COPD patients
Source: Annual Congress 2012 - Exercise testing in disease
Year: 2012
Dynamics of skeletal muscle reoxygenation after high-intensity exercise in mitochondrial myopathy
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008
Muscle morphology, metabolism and muscle function: general principles
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86
Year: 2003
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Effects of exercise on PGC1α in skeletal muscle of patients with COPD
Source: Annual Congress 2010 - Research development in exercise and gas exchange
Year: 2010
The responsiveness of skeletal muscle mRNAs to aerobic exercise training is not blunted in COPD
Source: International Congress 2019 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2019
Managing skeletal muscle dysfunction in COPD
Source: Eur Respir Mon 2013; 59: 164-173
Year: 2013
Dissociation between mitochondrial function and mitochondrial content in peripheral muscles of COPD patients
Source: Annual Congress 2007 - Advances in respiratory muscles
Year: 2007
Genetic variants predicting the response to endurance exercise training are also associated with skeletal muscle oxidative capacity in COPD
Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases
Year: 2017
The effects of L-carnitine supplementation on respiratory muscle strength and exercise tolerance in patients with mitochondrial myopathies
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Metabolic stress during exercise in the skeletal muscles of COPD patients
Source: Annual Congress 2003 - Exercise in COPD
Year: 2003
Effects of sildenafil intake on the dynamics of skeletal muscle oxygenation at the onset of and recovery from exercise in CHF
Source: Annual Congress 2012 - Exercise testing in disease
Year: 2012
Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
Effect of ageing on respiratory muscle endurance
Source: Eur Respir J 2002; 20: Suppl. 38, 498s
Year: 2002
Influence of respiratory muscle strength and body weight on exercise metabolism in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 490s
Year: 2001
Altered muscle metabolism and muscle mass in patients with COPD
Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases
Year: 2017
Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD
Source: Eur Respir J 2014; 44: 1188-1198
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept